STOCK TITAN

Orthopedia - KIDS STOCK NEWS

Welcome to our dedicated page for Orthopedia news (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on Orthopedia stock.

Overview

Orthopedia (KIDS) is a specialized medical device company dedicated exclusively to the field of pediatric orthopedics. Operating at the intersection of advanced medical technology and clinical expertise, the company designs, develops, and commercializes anatomically appropriate implants and surgical instruments. These innovative solutions are crafted to meet the distinct needs of pediatric patients, addressing conditions from long bone deformity correction and trauma management to spinal procedures and sports medicine. Keywords such as pediatric orthopedics, surgical implants, and clinical education reinforce the company’s technical focus from the very first introduction.

Core Business and Product Offering

At the heart of Orthopedia's operations lies a commitment to empowering pediatric orthopedic surgeons. The company’s product portfolio encompasses a range of state-of-the-art implants and instruments – each meticulously engineered to provide optimal treatment outcomes. Their offerings include specialized devices that aid in the correction of limb deformities, stabilization of fractures, and support for reconstructions, all designed with the care and precision that pediatric cases demand.

  • Dedicated Research and Development: Orthopedia invests in continuous innovation, leveraging cutting-edge technology to refine implant design and improve surgical outcomes.
  • Clinical and Educational Support: Beyond product development, the company emphasizes comprehensive clinical education and support programs that help surgeons stay updated on the latest procedures and applications.
  • Comprehensive Product Range: From long bone deformity correction to trauma, spine care, and sports medicine, the company offers an integrated suite of solutions tailored for pediatric needs.

Market Position and Industry Significance

Orthopedia has positioned itself as a trusted name within the pediatric orthopedic market. With an unwavering focus on quality and innovation, the company has developed an expertise that ensures its products meet rigorous safety and efficacy standards. Its dedicated approach sets it apart from competitors who cover broader orthopedic applications, as Orthopedia champions solutions specifically designed for children. This clear specialization has cemented its role as a key industry resource for surgeons looking for products that reliably address pediatric orthopaedic conditions.

Operational Excellence and Expertise

The company’s operational framework is built upon a solid foundation of expert knowledge and technical prowess. By integrating engineering innovation with clinical insight, Orthopedia ensures that every implant and instrument is both practical in a surgical environment and tailored for the unique demands of pediatric physiology. The emphasis on quality, reliability, and educational support further demonstrates a commitment to elevating standard practices within the field. This multifaceted approach underlines the company’s role as not only a supplier of medical devices, but also as a partner in advancing pediatric orthopedic care globally.

Customer and Stakeholder Focus

Orthopedia’s offerings are crafted with the end-user in mind, primarily targeting healthcare institutions and pediatric orthopedic surgeons. The company’s comprehensive support system includes detailed training and ongoing clinical education, ensuring that surgeons are capable of utilizing these advanced tools to their fullest potential. Through its balanced approach to innovation and education, Orthopedia helps customers achieve better surgical outcomes and improved quality of life for pediatric patients.

Conclusion

In summary, Orthopedia (KIDS) exemplifies an unwavering focus on the niche field of pediatric orthopedics. The company combines advanced product engineering, dedicated clinical support, and a targeted market strategy to address the specialized needs of pediatric surgical care. By maintaining a consistent emphasis on quality and clinical expertise, Orthopedia continues to serve as a central resource for pediatric orthopedic solutions in the healthcare industry.

Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announced participation in three virtual investor conferences in November 2020. Key executives, including CEO Mark Throdahl and COO Fred Hite, will represent the company. The events include the Credit Suisse 29th Annual Virtual Healthcare Conference on November 11, Stifel 2020 Virtual Healthcare Conference on November 18, and Canaccord Genuity 2020 Virtual MedTech & Diagnostics Forum on November 19. Investors can access the audio webcast on OrthoPediatrics' investor relations site.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.23%
Tags
conferences
-
Rhea-AI Summary

OrthoPediatrics Corp. (NASDAQ: KIDS) will release its third quarter 2020 financial results on November 4, 2020, after the market closes. A conference call to discuss these results is scheduled for November 5, 2020, at 8:00 a.m. ET. Interested participants can join the call using the provided domestic and international dial-in numbers. OrthoPediatrics, founded in 2006, focuses on pediatric orthopedics, offering 35 surgical systems across multiple categories and serving markets in the U.S. and 43 other countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.38%
Tags
conferences earnings
-
Rhea-AI Summary

OrthoPediatrics Corp. (KIDS) announced its support for the 3rd Annual PediOrtho WEST Resident Education Course, scheduled for October 16-17 in Sacramento, California. The course aims to provide orthopedic residents with essential training in pediatric orthopedic techniques through both lectures and hands-on labs, facilitated by expert surgeons. President David Bailey emphasized the company's commitment to advancing pediatric orthopedic education globally, enhancing outcomes for aspiring surgeons.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.37%
Tags
none
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announces continued support for the Scoliosis Research Society (SRS) with Gold Level sponsorship for its 55th Annual Meeting, running virtually from September 9-13. Additionally, the company will be a Platinum Level Sponsor for the American Academy for Cerebral Palsy and Developmental Medicine (AACPDM) 74th Annual Meeting from September 23-26. OrthoPediatrics will offer educational grants and scholarships for physicians attending these events, contributing to discussions and showcasing its products through virtual exhibits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.2%
Tags
none
-
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announced participation in the Morgan Stanley 18th Annual Global Healthcare Conference on September 15, 2020. Key executives, including CEO Mark Throdahl and CFO Fred Hite, will engage in a fireside chat and one-on-one meetings starting at 4:15 PM ET. The event will take place virtually, with an audio webcast accessible on the company’s investor relations website. OrthoPediatrics specializes in pediatric orthopedic products, boasting 35 surgical systems for trauma, scoliosis, and sports medicine across 43 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
conferences
-
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announced the completion of its 1,000th surgery using the Pediatric Nailing Platform | FEMUR (PNP | FEMUR), a system designed for pediatric femur fracture treatment. This innovative intramedullary nailing system, which received FDA 510(k) clearance in 2018, addresses specific anatomical needs of children and adolescents. With a comprehensive range of sizes and instrumentation, the PNP system represents OrthoPediatrics' commitment to improving pediatric orthopedic solutions, building on nearly a decade of learning from its original PediNail system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.48%
Tags
none
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) has announced its sponsorship for the virtual 30th Annual Baltimore Limb Deformity Course (BLDC) on August 29-30, 2020. The company will provide scholarships for residents and fellows to access the course. Utilizing its DocMatter and VuMedi platforms, OrthoPediatrics will share educational video content on its innovative Orthex frame, aimed at correcting limb deformities. CEO Mark Throdahl emphasized the importance of BLDC for pediatric surgeons and the effectiveness of virtual interactions in advancing orthopedic care for children.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
none
-
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) announced participation in the 5th Annual Needham Virtual Med Tech 1x1 Conference. CEO Mark Throdahl, COO Fred Hite, and President Dave Bailey will host virtual investor meetings on August 17, 2020. Interested investors can schedule one-on-one calls by contacting their Needham representative or Emma Poalillo at The Ruth Group.

Founded in 2006, OrthoPediatrics focuses on pediatric orthopedics, offering 35 surgical systems across trauma, scoliosis, and sports medicine categories. The company operates globally, serving the U.S. and 43 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.74%
Tags
conferences
-
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) reported a 25.3% decline in total revenue for the second quarter of 2020, amounting to $13.6 million, largely due to the effects of the COVID-19 pandemic. U.S. revenue decreased by 12.3% to $12.1 million, while international revenue plummeted 66.8% to $1.4 million. Despite challenges, the company initiated the U.S. launch of the ApiFix system and expanded its sales team by 7.9%. Operating loss increased to ($7.0 million), compared to ($1.8 million) last year, while net loss was ($9.4 million), leading to a net loss per share of ($0.54).

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.54%
Tags
Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS) has achieved a milestone by completing its 500th case using the FIREFLY® Pedicle Screw Navigation Guides in collaboration with Mighty Oak Medical. This technology enhances surgical efficiency and patient safety by utilizing AI for presurgical planning. It reduces intraoperative radiation and speeds up screw placement, making it a cost-effective alternative to traditional navigation systems. The technology is designed specifically for pediatric orthopedic surgeries, aiming to improve outcomes for children with scoliosis and spinal deformities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.76%
Tags
none

FAQ

What is the current stock price of Orthopedia (KIDS)?

The current stock price of Orthopedia (KIDS) is $25.05 as of April 1, 2025.

What is the market cap of Orthopedia (KIDS)?

The market cap of Orthopedia (KIDS) is approximately 611.8M.

What is Orthopedia's core business?

Orthopedia focuses exclusively on pediatric orthopedics, designing and developing specialized implants and surgical instruments tailored for children.

How does Orthopedia differentiate itself from other orthopedic companies?

By concentrating solely on pediatric applications, Orthopedia provides anatomically precise implants and comprehensive clinical education, addressing the unique challenges of pediatric orthopedic care.

What types of products does Orthopedia offer?

The company offers a broad range of products including implants for long bone deformity correction, trauma management, spine care, and sports medicine, along with specialized surgical instruments.

Who are the primary customers of Orthopedia?

Orthopedia primarily serves pediatric orthopedic surgeons and healthcare institutions, providing them with both the necessary surgical devices and clinical educational support.

How does Orthopedia support clinical education?

The company offers ongoing training and educational programs designed to keep surgeons informed about the latest techniques and proper use of their specialized implants and instruments.

What is the significance of technology and innovation for Orthopedia?

Orthopedia leverages cutting-edge technology to continually improve its products, ensuring that its implants and instruments meet the high safety and efficacy standards required in pediatric care.

How does Orthopedia ensure product quality?

The company adheres to rigorous research and development protocols, integrating clinical insights with advanced engineering practices to maintain the highest quality standards in its products.
Orthopedia

Nasdaq:KIDS

KIDS Rankings

KIDS Stock Data

611.78M
16.15M
32.42%
71.18%
4.02%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
WARSAW